| Year |
Citation |
Score |
| 2012 |
Bromberg O, Frisch BJ, Weber JM, Porter RL, Civitelli R, Calvi LM. Osteoblastic N-cadherin is not required for microenvironmental support and regulation of hematopoietic stem and progenitor cells. Blood. 120: 303-13. PMID 22596259 DOI: 10.1182/Blood-2011-09-377853 |
0.786 |
|
| 2012 |
Calvi LM, Bromberg O, Rhee Y, Weber JM, Smith JN, Basil MJ, Frisch BJ, Bellido T. Osteoblastic expansion induced by parathyroid hormone receptor signaling in murine osteocytes is not sufficient to increase hematopoietic stem cells. Blood. 119: 2489-99. PMID 22262765 DOI: 10.1182/Blood-2011-06-360933 |
0.829 |
|
| 2012 |
Frisch BJ, Shafiq I, Porter RL, Weber JM, Smith JN, Bromberg O, Basil M, Dhillon RS, Schwarz EM, Calvi LM. Intermittent in Vivo Parathyroid Hormone (PTH) Treatment Results in Jagged 1 (Jag 1) Dependent and Independent Effects On Hematopoietic Stem Cells (HSCs) Blood. 120: 642-642. DOI: 10.1182/Blood.V120.21.642.642 |
0.79 |
|
| 2011 |
Smith JN, Weber JM, Calvi LM. PTH Stimulates Osteoblastic VEGF-A Production and Remodels Bone Marrow Micro-Endothelial Structures Blood. 118: 722-722. DOI: 10.1182/Blood.V118.21.722.722 |
0.765 |
|
| 2010 |
Weber JM, Calvi LM. Notch signaling and the bone marrow hematopoietic stem cell niche. Bone. 46: 281-5. PMID 19679213 DOI: 10.1016/J.Bone.2009.08.007 |
0.771 |
|
| 2009 |
Frisch BJ, Porter RL, Gigliotti BJ, Olm-Shipman AJ, Weber JM, O'Keefe RJ, Jordan CT, Calvi LM. In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells. Blood. 114: 4054-63. PMID 19726721 DOI: 10.1182/Blood-2009-03-205823 |
0.802 |
|
| 2009 |
Weber JM, Frisch BJ, Porter RL, Bromberg O, Olm-shipman AJ, Awad H, Calvi LM. In Vivo Parathyroid Hormone Treatment Expands All Multipotent Primitive Hematopoietic Cell Subsets. Blood. 114: 1449-1449. DOI: 10.1182/Blood.V114.22.1449.1449 |
0.806 |
|
| 2007 |
Frisch BJ, Weber JM, Porter RL, Gigliotti BJ, Smith JN, Olm-Shipman AJ, O’Keefe RJ, Jordan CT, Calvi LM. In Vivo Treatment with Prostaglandin E2 (PGE2) Selectively Expands Short-Term Hematopoietic Stem Cells. Blood. 110: 1254-1254. DOI: 10.1182/Blood.V110.11.1254.1254 |
0.79 |
|
| 2006 |
Weber JM, Forsythe SR, Christianson CA, Frisch BJ, Gigliotti BJ, Jordan CT, Milner LA, Guzman ML, Calvi LM. Parathyroid hormone stimulates expression of the Notch ligand Jagged1 in osteoblastic cells. Bone. 39: 485-93. PMID 16647886 DOI: 10.1016/J.Bone.2006.03.002 |
0.799 |
|
| 2006 |
Calvi LM, Frisch BJ, Gigliotti BJ, Christianson CA, Weber JM, Jordan CT, O’Keefe RJ. Prostaglandin E2 (PGE2) Regulates Osteoblastic Jagged1 and Expands Primitive Hematopoietic Cells In Vivo. Blood. 108: 89-89. DOI: 10.1182/Blood.V108.11.89.89 |
0.836 |
|
| 2005 |
Forsythe SR, Weber JM, Christianson CA, Gigliotti BJ, Frisch BJ, Calvi LM. Osteoblastic Cells (OBs) and the Hematopoietic Microenvironment: Parathyroid Hormone (PTH) Increases the Notch Ligand Jagged1 (J1) in a Specific Subpopulation of OBs. Blood. 106: 1396-1396. DOI: 10.1182/Blood.V106.11.1396.1396 |
0.822 |
|
| 2004 |
Calvi LM, Shin HI, Knight MC, Weber JM, Young MF, Giovannetti A, Schipani E. Constitutively active PTH/PTHrP receptor in odontoblasts alters odontoblast and ameloblast function and maturation. Mechanisms of Development. 121: 397-408. PMID 15110049 DOI: 10.1016/J.Mod.2004.02.004 |
0.688 |
|
| 2004 |
Calvi LM, Weber JM, Guzman ML, Christianson CA, Milner LM, Jordan CT. Osteoblastic Cells and the Hematopoietic Microenvironment: The Notch ligand Jagged1 Is Increased in Osteoblastic Stromal Cells by Parathyroid Hormone (PTH)Treatment. Blood. 104: 1284-1284. DOI: 10.1182/Blood.V104.11.1284.1284 |
0.773 |
|
| 2003 |
Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 425: 841-6. PMID 14574413 DOI: 10.1038/Nature02040 |
0.779 |
|
| Show low-probability matches. |